10 Best High Dividend Stocks To Invest In Right Now

Last week was a great week to be a dividend investor. Not only did two of my top stocks declare fresh dividends, but both companies also raised those payouts. The ability to enjoy a rising dividend is one reason why I much prefer the income from my dividend stocks than the fixed rate I could be earning on a bond.

But not all dividend-paying stocks are equal. Some companies pay unsustainably high dividends, which is why it is important to double check the company's ability to actually pay its dividend, even if a raise would suggest investors have nothing to fear. With that in mind, let's drill down a bit deeper into the two companies that just gave me a raise.

A gushing of income growth
Oil and gas production company, ConocoPhillips (NYSE: COP  ) , announced that it was providing investors with a 4.5% raise this week. The company's CEO, Ryan Lance, pointed out that "[a] compelling dividend is a key part of our offering to shareholders and this increase is aligned with our commitment to target consistent dividend growth over time." This is actually the first raise investors have seen in a while because the company has been in the process of a major three-year repositioning program in which it shed billions of dollars in assets, including its refining arm Phillips 66 (NYSE: PSX  ) .

Top 10 Small Cap Stocks To Own Right Now: BCE Inc. (BCE)

BCE Inc. provides communications solutions to residential, business, and wholesale customers primarily in Canada. The company offers local and long distance telephone services under the Bell Home Phone brand; direct-to-home satellite television (TV) services under the Bell TV name; Internet protocol TV services under the Bell Fibe TV brand; and personal video recorders and online access services. It also provides data services, including Internet access services under the Bell Internet name; Internet protocol based services; and information and communications technology solutions. In addition, the company engages in the rental, sale, and maintenance of business terminal equipment; sale of TV set-top boxes; and provision of network installation and maintenance services for third parties. Further, it offers wireless voice and data communications products and services, such as call display and voicemail, e-mail, Web browsing, social networking, text, picture and video messagi ng, music downloads, ring tunes, ringtones, games and applications, video streaming, live TV, mobile Internet, roaming, and global positioning system navigation services under the Bell and Virgin Mobile brands. Additionally, the company provides media services comprising TV programming services to broadcast distributors. It operates approximately 28 conventional over-the-air stations and 30 English and French-language specialty TV channels; 33 FM and AM radio stations and their related Websites; and Theloop.ca Website. As of December 31, 2012, the company served approximately 2.1 million high-speed Internet access customers through fiber-optic, digital subscriber line, or wireless broadband technology; and 7.7 million wireless customers. BCE Inc. offers its services through call centre representatives, independent dealer stores, and value-added resellers, as well as through its Websites. The company was founded in 1880 and is headquartered in Verdun, Canada.

Advisors' Opinion:

• [By Alex Planes]

  Excel became the youngest company to earn a billion dollars annual revenue that year, and was also considered the fourth-largest long-distance carrier by the end of 1996. But the flaws in its business model became too great to ignore as more Americans shifted their calling preferences to mobile phones. Profits plummeted, and after the turn of the century Bell Canada (NYSE: BCE  ) , a major shareholder, acquired full control. Excel became a Bell Canada subsidiary, but was quickly spun off as a new privately held company, only to have this new corporate parent file for bankruptcy in 2004. After emerging from bankruptcy, the former Excel was eventually acquired by another privately held telecom provider. It wasn't the first or the fastest to go big and then go bust, but Excel's story highlights the risks any investor takes in buying up shares based on a very brief history of meteoric growth.

10 Best High Dividend Stocks To Invest In Right Now: Biogen Idec Inc(BIIB)

Biogen Idec Inc. discovers, develops, manufactures, and markets therapies for the treatment of neurodegenerative diseases, hemophilia, and autoimmune disorders in the United States and internationally. Its marketed products include the AVONEX for the treatment of relapsing multiple sclerosis (MS); RITUXAN for treating relapsed or refractory, CD20-positive, and B-cell Non-Hodgkin?s lymphoma (NHL); TYSABRI to treat relapsing MS; FUMADERM for the treatment of severe plaque psoriasis in adult patients; and FAMPYRA, an oral compound for the improvement of walking in adult patients with MS with walking disability. Biogen Idec Inc.?s products under Phase III consist of PEGylated interferon beta-1a designed to prolong the effects and reduce the dosing frequency of interferon beta-1a; BG-12 for the treatment of MS; Daclizumab, a monoclonal antibody in relapsing MS; Long-lasting factor IX and VIII fusion protein for the treatment of hemophilia B; GA101, a monoclonal antibody for t he treatment of chronic lymphocytic leukemia and NHL; and Dexpramipexole, an orally administered small molecule for the treatment of amyotrophic lateral sclerosis. The company?s Phase I clinical trial products include Anti-LINGO for use in multiple sclerosis, Neublastin for use in neuropathic pain, CD40L for use in systemic lupus erythematosus, ANTI-TWAEK humanized monoclonal antibody for TWEAK, and BIIB037 for use in Alzheimer's disease; and Phase II clinical trial product comprises OCRELIZUMAB, a humanized monoclonal antibody for treating CD20. It has collaboration agreements with Genentech, Inc.; Elan Pharma International, Ltd; Acorda Therapeutics, Inc.; Portola Pharmaceuticals, Inc.; Swedish Orphan Biovitrum AB; Abbott Biotherapeutics Corp; and Vernalis plc. The company was formerly known as IDEC Pharmaceuticals Corporation and changed its name to Biogen Idec Inc. in November 2003. Biogen Idec Inc. was founded in 1985 and is headquartered in Weston, Massachusetts.

Advisors' Opinion:

• [By Philip Springer]

  Just last week, the major US stock averages hit all-time highs, led by large-cap stocks, including some that had been lagging for many years. But it’s been a different story in March-April for stocks that had the biggest gains of 2013 and early this year.
  
  This week brought more bad news for the stock market’s two most overvalued sectors, biotechnology and information technology. Worse, when the paddy wagon came, as usual it took the good stocks with the bad, to rephrase an old Wall St. aphorism in politically correct terms.
  
  Yesterday, the technology-heavy Nasdaq Composite Index tumbled 3.1 percent, its �biggest one-day drop in nearly 2陆 years. This dragged the broader market sharply lower, as investors resumed selling biotechnology stocks in general and many technology stocks. As of April 10, the Nasdaq Composite was 7 percent off its 14-year high, which was reached last month. Yet the S&P 500 and Dow Jones Industrial Average remain not far from their all-time record peaks, down 3 percent and 2.5 percent respectively.
  
  There are many reasons for the decline of both the junk and the good growth stocks. First, the broad market has been long overdue for a 10 percent correction, which still hasn’t occurred.
  
  Second, the high fliers were much more overdue for a reality check. These particularly include extremely overvalued companies in social media, the “cloud,” 3d printing, biotechnology and more.
  
  Third, the new-issues market, which naturally has consisted primarily of info tech and biotech issues, created too much new supply that inevitably dampened investor demand for the more established companies in those sectors.
  
  The increased importance of trading exchange-traded funds, as both a way to invest and to hedge against market declines, inevitably adds to the downward pressure in this situation.� Reason: Shares of all of their components are sold, regardless of each stock’s relative me

10 Best High Dividend Stocks To Invest In Right Now: Acura Pharmaceuticals Inc.(ACUR)

Acura Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and manufacture of pharmaceutical product candidates utilizing its proprietary Aversion and Impede technologies. Its Aversion Technology is a proprietary platform technology providing abuse deterrent features and benefits to orally administered pharmaceutical drug products containing abusable active ingredients, such as tranquillizers, stimulants, sedatives, and decongestants. The company offers OXECTA Tablets CII, which are oral formulations of oxycodone HCl for the management of acute and chronic moderate to severe pain; and Impede PSE, a pseudoephedrine hydrochloride tablet product candidate. It is also developing opioid analgesic product candidates, which would be used to relieve pain while discouraging common methods of opioid product misuse and abuse, including intravenous injection of dissolved tablets or capsules; nasal snorting of crushed tablets or capsules; and intentional swallowing of excess quantities of tablets or capsules. In addition, the company investigates and develops mechanisms to incorporate abuse deterrent features into abused and misused pharmaceutical products using its Impede Technology. Acura Pharmaceuticals, Inc. has a license, development, and commercialization agreement with King Pharmaceuticals Research and Development, Inc. to develop and commercialize certain opioid analgesic products utilizing the company?s proprietary Aversion Technology in the United States, Canada, and Mexico. The company was founded in 1935 and is based in Palatine, Illinois.

Advisors' Opinion:

• [By Rick Munarriz]

  Thursday
  Acura Pharmaceuticas (NASDAQ: ACUR  ) checks in on Thursday. Drugmakers use Acura's Aversion and Impede technologies to create abuse-deterrent treatments. In short, if an abuser tries to extract the active ingredient of a drug to heighten addictive experiences, Acura's technologies kick in to make the whole dose unusable.

• [By John Udovich]

  On Tuesday, small cap specialty pharmaceutical company�Acura Pharmaceuticals, Inc (NASDAQ: ACUR) surged 27.52% to $1.90 on no apparent news beyond a speculative Seeking Alpha article that talked about certain catalysts����meaning its worth taking a closer look at the company to see what�� going on and whether shares could move higher.�

10 Best High Dividend Stocks To Invest In Right Now: Gulf Resources Inc (GURE)

Gulf Resources, Inc. (Gulf Resources), incorporated on February 28, 1989, is engaged in manufacturing and trading of bromine and crude salt, and manufacturing and selling of chemical products used in oil and gas field exploration, oil and gas distribution, oil field drilling, wastewater processing, papermaking chemical agents and inorganic chemicals. As of December 31, 2011, its products have been sold only within the People�� Republic of China. The Company operates in three segments: bromine, crude salt and chemical products. It manufactures and trades bromine and crude salt through Shouguang City Haoyuan Chemical Company Limited (SCHC), and manufactures chemical products for use in the oil industry and paper manufacturing industry through Shouguang Yuxin Chemical Industry Co., Limited (SYCI). On December 22, 2011, the Company acquired substantially all of the assets owned by Liangcai Zhang in the Shouguang City Yangkou Township Area.

Bromine and Crude Salt

The Company manufactures and distributes bromine through its wholly owned subsidiary, SCHC. Bromine (Br2) is a halogen element and it is a red volatile liquid at standard room temperature, which has reactivity between chlorine and iodine. Elemental bromine is used to manufacture a variety of bromine compounds used in industry and agriculture. Bromine is also used to form intermediates in organic synthesis. Its bromine is used in brominated flame retardants, fumigants, water purification compounds, dyes, medicines and disinfectants. Its production sites are located in the Shandong Province in northeastern China. Its production feeds include natural brine, vitriol, chlorine, sulfur and coal.

Crude Salt

The Company also produces crude salt, which is produced from the evaporation of the wastewater after its bromine production process. Once the brine is returned to the surface and the bromine is removed, the remaining brine is pumped to onsite containing pools and then exposed to natural sunshine. T! his causes the water to evaporate from the brine, resulting in salt being left over afterwards. Crude salt is the principal material in alkali production, as well as chlorine alkali production and is used in the chemical, food and beverage, and other industries.

Chemical Products

The Company produces chemical products through its wholly owned subsidiary, SYCI. The products it produces include hydroxyl guar gum, demulsified agent, corrosion inhibitor for acidizing, bactericide, chelant, iron ion stabilizer, clay stabilizing agent, flocculants agent, remaining agent, expanding agent, bromopropane, environmental friendly additive products, solid lubricant and polyether lubricant.

Gulf Resources competes with Shandong Yuyuan Group Company Limited, Shandong Haihua Group Company Limited, Shandong Dadi Salt Chemical Group Company Limited, Shandong Haiwang Chemical Company Limited, Shandong Weifang Longwei Industrial Company Limited, Shandong Caiyangzi Saltworks, Beijing Tianqing Chemical Company Limited, Shandong Weifang Shuangxing Pesticides Company Limited, Zibo Dacheng Pesticides Company Limited, Befar Group Company Limited, China Eastar (Group) Chemical Industry Company Limited and Pecome Technologies Limited.

Advisors' Opinion:

• [By Roberto Pedone]

  Another under-$10 basic materials player that's starting to move within range of triggering a major breakout trade is Gulf Resources (GURE), which manufactures and trades bromine and crude salt, and manufactures and sells chemical products used in oil and gas field exploration. This stock has been a favorite target of the bulls so far in 2013, with shares up sharply by 140%.

  If you take a look at the chart for Gulf Resources, you'll notice that this stock has been uptrending strong for the last six months, with shares soaring higher from its low of $1.10 to its recent high of $3.10 a share. During that uptrend, shares of GURE have been consistently making higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of GURE within range of triggering a major breakout trade.

  Market players should now look for long-biased trades in GURE if it manages to break out above some near-term overhead resistance levels at $2.87 to its 52-week high at $3.10 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 467,986 shares. If that breakout hits soon, then GURE will set up to enter new 52-week high territory, which is bullish technical price action. Some possible upside targets off that breakout are $4 to $4.50 a share.

  Traders can look to buy GURE off any weakness to anticipate that breakout and simply use a stop that sits right below some near-term support levels at $2.38 a share, or near its 50-day moving average of $2.23 a share. One can also buy GURE off strength once it starts to clear those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

• [By Paul Ausick]

  Big Earnings Movers: Gogo Inc. (NASDAQ: GOGO) is up 28.3% at $24.05. Gulf Resources Inc. (NASDAQ: GURE) is up 15.8% at $2.46.

  Stocks on the Move: ViroPharma Inc. (NASDAQ: VPHM) is up 25.4% at $49.38 on a $4.2 billion buyout offer from London-listed Shire. Zalicus Inc. (NASDAQ: ZLCS) is down 72.3% at $1.30 on a failed drug trial.

10 Best High Dividend Stocks To Invest In Right Now: Natura Cosmeticos SA (NATU3)

Natura Cosmeticos SA is a Brazil-based company that, together with its subsidiaries, is engaged in the manufacture, industrialization, distribution and commercialization of cosmetics, fragrances and personal hygiene products under the brand name Natura. The Company's product line includes deodorants, makeup, sunscreens, lotions, creams, lipsticks and perfumes, among others. It operates in Chile, Peru, Argentina, Mexico, Colombia, Spain and Netherlands, among others, and, as of December 31, 2011, the Company had such subsidiaries as Industria e Comercio de Cosmeticos Natura Ltda, Natura Cosmeticos SA, Natura Cosmeticos de Mexico SA de CV, Natura Cosmeticos Espana SL, Natura (Brasil) International BV and Natura Inovacao e Tecnologia de Produtos Ltda, among several others. On February 28, 2013, the Company concluded the acquisition of a 65% stake in Emeis Holdings Pty Ltd, operating under Aesop brand. Advisors' Opinion:

• [By Harry Suhartono]

  Brazil�� Ibovespa rose for a third day as traders pared bets on higher borrowing costs in Brazil, boosting the outlook for companies that sell in the local market. B2W Cia. Digital led gains among retailers, with Lojas Americanas SA (LAME3) and Natura Cosmeticos SA (NATU3) also trading higher. Petrochemicals producer Braskem SA (BRKM5) was the worst performer on the equity gauge after O Estado de S.Paulo reported Petroleo Brasileiro SA (PETR4) is seeking to raise prices of naphtha sold to the company by 5 percent.

10 Best High Dividend Stocks To Invest In Right Now: Synergetics USA Inc.(SURG)

Synergetics USA, Inc., a medical device company, engages in the design, manufacture, and marketing of microsurgical instruments and consumables primarily for ophthalmology and neurosurgery markets in the United States and internationally. The company?s product lines focus upon precision engineered, microsurgical, handheld devices, and the microscopic delivery of laser energy, ultrasound, electrosurgery, aspiration, illumination and irrigation that are delivered in multiple combinations. It offers retinal surgical items, including handheld disposable and reusable forceps and scissors, fiberoptics for illumination and photocoagulation, cannulas, scrapers, and other reusable and disposable surgical devices. The company also provides bipolar electrosurgical generators; lesion generators used for minimally invasive pain treatment; and directional laser probes, as well as offers gauge instrumentation to the vitreoretinal surgical market. It sells its products through direct sale s employees, distributors, and independent sales representatives. The company was founded in 1991 and is headquartered in O?Fallon, Missouri.

Advisors' Opinion:

• [By Monica Gerson]

  Synergetics USA (NASDAQ: SURG) is projected to post its Q4 earnings at $0.06 per share on revenue of $17.01 million.

  Team (NYSE: TISI) is expected to post its Q1 earnings at $0.36 per share on revenue of $176.70 million.

• [By Ben Levisohn]

  Synergetics USA (SURG) has dropped 4.8% to $4.75 after the medical device company said it earned 6 cents a share, in line with analyst forecasts.

  Team Inc.�(TISI) has dropped 11% after the company missed its earnings forecast and lowered guidance.

• [By Monica Gerson]

  Synergetics USA (NASDAQ: SURG) reported its FQ4 earnings of $0.06 per share on revenue of $17.9 million. However, analysts were projecting earnings of $0.05 per share on revenue of $17 million. Synergetics USA shares dipped 11.82% to $4.40 in the after-hours trading session.

10 Best High Dividend Stocks To Invest In Right Now: Dno International ASA (DTNOF.PK)

DNO International ASA is a Norway-based oil and gas exploration and production company. It is engaged in the acquisition, development and operation of oil and gas properties. Its activities are primarily undertaken in the Middle East and the North African (MENA) region. It holds stakes in oil and gas blocks in various stages of exploration, development and production both onshore and offshore in the Kurdistan region of Iraq, the Republic of Yemen, the Sultanate of Oman, the United Arab Emirates, the Tunisian Republic and Somaliland. The Company operates through its head office in Oslo, and a network of offices throughout the MENA region. Its subsidiaries include DNO Yemen AS, DNO UK Ltd, DNO Invest AS, DNO Tunisia AS, DNO Iraq AS and DNO Mena AS. In January 2014, it completed the the farm-in by its subsidiary DNO Tunisia AS to the Sfax Offshore Exploration Permit and the Ras El Besh Concession in Tunisia, in which DNO Tunisia AS now holds 87.5% participating (100% paying) interest. Advisors' Opinion:

• [By Street Smart Investor]

  DNO International (DTNOF.PK), an independent exploration and production company, has surged by 43% in 2013. The upside trend is not over for the stock with potential triggers for further upside over the next one year. This research presents the reasons for the bullish outlook and the stock's upside potential considering the best case and worst case scenario for the company. The scenario analysis concludes on a 25-42% upside in the given time horizon.